Close Menu

NEW YORK – The GenomeWeb Index rose more than 6 percent in November, as several stock saw gains in the double digits.

The index outperformed the Dow Jones Industrial Average and the Nasdaq — which gained nearly 4 percent and nearly 5 percent, respectively — but underperformed the Nasdaq Biotechnology Index, which gained more than 11 percent. Individual stock performance in the GenomeWeb Index was mostly positive as 24 of the 31 stocks saw gains and seven saw losses.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.